Navigation Links
Campbell Alliance to Release New Forward-Looking Industry Report on Deal-Making Trends at the 2013 BIO International Convention
Date:4/19/2013

ven in the face of different commercial projections."

Specifically for in-licensers, 2013 may be a great time to pursue early-stage oncology assets, while they can expect to face competition for clinical-stage and marketed oncology assets.  Similarly, early-stage antibiotic and dermatology assets are relative buyers' markets.  Other therapeutic areas are relative sellers' markets and must be approached with due consideration.  It is important for in-licensers to remain objective in valuing assets and to carefully weigh the organizational fit of assets under consideration.

"For out-licensers, the market appears to be shifting in their favor," added Stewart. "To turn this positive outlook into successful deals, however, out-licensers will need to provide more pricing and market access justification in their non-confidential materials and bridge the valuation gap through credible validation of the commercial opportunity."

A summary of the study results will be presented during a Super Session at the BIO International Convention on Wednesday, April 24 at 2:00pm CT, followed by a panel discussion involving senior industry executives. Panelists for this Super Session will include:

  • William Hait , MD, PhD – Global Head, Janssen Research & Development LLC, Janssen
  • Bahija Jallal , PhD – Executive Vice President, R&D, MedImmune
  • John Leonard , MD – Senior Vice President, Chief Scientific Officer, AbbVie
  • Roger Pomerantz – Worldwide Head of Licensing & Acquisitions, Senior Vice President, Merck Research Labs
  • Chihiro Yokota , RPh – Corporate Executive, Global Head, Business Development and Licensing & Alliances, Astellas Pharma Inc.

Additiona
'/>"/>

SOURCE Campbell Alliance
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Campbell Alliance Launches Market Research and Analytics Group, Appoints Michael Turner as General Manager of Encuity Research
2. SoundConnect Announces New Not-For-Profit Customer in Smart Card Alliance
3. Alliance to Feed the Future Congratulates Our Farmers, Supports Education for Future Generations on National Agriculture Day
4. The Alliance for Regenerative Medicine forms Tissue Engineering and Biomaterials Committee
5. China Cord Blood Corporation and Cordlife Group Limited Foster Closer Alliance Across Asia
6. BioPower Operations Corporation Announces that FTZ Exchange Signs Strategic Alliance with Capacity 360, LLC and Tom Settineri
7. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
8. iBio, Inc. and GE Healthcare form new global alliance
9. Afraxis and PsychoGenics Form Alliance to Offer Afraxis ESP Technology for Drug Discovery
10. Genomind to Participate in National Alliance on Mental Illness (NAMI) 2012 National Convention
11. Clean Energy Alliance and the Manufacturing Extension Partnership Announce New Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... York, NY (PRWEB) December 16, 2014 ... significant changes since 2013, which is why IBISWorld updated ... this industry continues to benefit from an intensified focus ... the proposal for new emission standards for power plants ... industry operators. According to IBISWorld Industry Analyst Sarah Kahn, ...
(Date:12/17/2014)... Bellingham, Washington, USA (PRWEB) December 16, 2014 ... Kirstin Baum, manager at Philipps- Universität Marburg’s Department ... optics and photonics, in the newly released ... 2015-2016. “And never be too shy to ask ... STEM (science, technology, engineering, and mathematics) occupations ranging ...
(Date:12/17/2014)... RIDGE, N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today ... mg (referred to as Somatuline®) was approved by ... the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in ... locally advanced or metastatic disease to improve progression-free ...
(Date:12/17/2014)... 17, 2014 This report is ... Tubing industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry has witnessed rapid development with key ... acquisitions. This report mentions quartz tubing upstream raw ...
Breaking Biology Technology:Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 82020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2
... 28, 2011 , Spherix Incorporated (NASDAQ: ... for therapy in diabetes, metabolic syndrome and atherosclerosis, and ... supplement, biotechnology and pharmaceutical companies – today announced the ... of shares of its common stock together with warrants ...
... Bioceuticals, a wholly owned subsidiary of Mistral Ventures (MILV.pk), ... pulmonary disease market (COPD) with the completed acquisition of ... medicine was developed for the treatment of COPD, the ... Chronic Bronchitis. We believe that there is no other ...
... of Colorado Boulder study shows that huge amounts of ... promote healthy heart growth, results that may have implications ... Leinwand and her research team found the amount of ... oils -- in the blood of Burmese pythons one ...
Cached Biology Technology:Spherix Announces Closing of Private Placement of $1.25 Million, Discusses Use of Proceeds 2Spherix Announces Closing of Private Placement of $1.25 Million, Discusses Use of Proceeds 3Nature's Bioceuticals Enters Chronic Obstructive Pulmonary Disease Market After Acquiring Breakthrough Breathing Formula 2Nature's Bioceuticals Enters Chronic Obstructive Pulmonary Disease Market After Acquiring Breakthrough Breathing Formula 3CU-Boulder python study may have implications for human heart health 2CU-Boulder python study may have implications for human heart health 3CU-Boulder python study may have implications for human heart health 4
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM ... Practices (GCP) audit to confirm its adherence to ... This accomplishment enables HITLAB to conduct regulated smart ... highest principles for patient safety and research quality. ... healthcare access, quality, and delivery with innovative technology," ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and ... the addition of the "Global Chemical Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 ... the increasing demand for medical sensors in biomedical ... data for quick and correct diagnosis during surgical ...
(Date:12/15/2014)... 2014 Research and Markets ( ... "Global Facial Recognition Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is a ... recognition system measures the overall facial feature of ... and the distance between eyes. Facial recognition is ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... ( Caretta caretta ) and fishing gear such as longline ... effects of climate change on these animals. In order to ... for fishermen, the scientists are proposing that fishing in the ... areas more than 35 nautical miles from land. Populations ...
... colon cancer cells, may help identify patients at risk ... by Vanderbilt-Ingram Cancer Center researchers. The findings, published ... help personalize treatments for colon cancer the second ... by identifying patients most likely to benefit from ...
... MADISON A team of University of ... friendly process that selectively converts gamma-valerolactone, a biomass ... The simple process preserves about 95 percent ... little hydrogen input, and captures carbon dioxide under ...
Cached Biology News:How can accidental captures of loggerhead turtles be reduced? 2Gene signature may improve colon cancer treatment 2Gene signature may improve colon cancer treatment 3New process yields high-energy-density, plant-based transportation fuel 2
RABBIT ANTI ISOCITRATE DEHYDROGENASE...
Recombinant Feline IL-5...
dithiothreitol (DTT) Reactive Dyes and Chemicals Thiol-Reactive Dyes, Haptens and Quenchers Reducing Agents...
Recombinant Feline IL-2, CF...
Biology Products: